Detection of genomic alterations in liquid biopsies from patients with non-small cell lung cancer using FoundationOne Liquid CDx: a cost-effectiveness analysis
Por:
Isla D, Alvarez R, Arnal M, Arriola E, Azkarate A, Azkona E, Garcia-Campelo R, Garrido P, Nadal E, Ortega A, Carcedo D, Crespo M, Lavara J, Corcoles F, Bernabe R
Publicada:
31 dic 2024
Resumen:
|